Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. Recalls

All product recalls associated with Teva Pharmaceuticals USA, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

266

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 261–266 of 266 recalls

Copaxone Injection (Teva) – Foreign Particle Risk (2012)

Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

Class IIModerate

FDAMay 18, 2012Nationwide• Teva Pharmaceuticals USA, Inc.

Metoprolol Tartrate Tablets (Teva) – Weight Specification Issue (2012)

Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

Class IIModerate

FDAMay 16, 2012OH• Teva Pharmaceuticals USA, Inc.

Zeosa Birth Control (Teva) – impurity specifications (2012)

Impurities/Degradation: This recall is being carried out due to the potential for some lots not meeting impurity specifications.

1...12 1314

Page 14 of 14Next

Class II

Moderate

FDAMay 2, 2012Nationwide• Teva Pharmaceuticals USA, Inc.

Cabergoline Tablets (Teva) – impurity specification (2012)

Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

Class IIILow

FDAApr 24, 2012Nationwide• Teva Pharmaceuticals USA, Inc.

Jolessa Tablets (Teva) – contraceptive sequence issue (2012)

Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

Class IIILow

FDAApr 23, 2012Nationwide• Teva Pharmaceuticals USA, Inc.

Mefloquine HCL Tablets (Teva) – weight inconsistency (2012)

Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.

Class IIModerate

FDAApr 2, 2012Nationwide• Teva Pharmaceuticals USA, Inc.